| scholarly article | Q13442814 |
| P50 | author | W Ray Kim | Q79788662 |
| P2093 | author name string | Jennifer Warner | |
| Terry M Therneau | |||
| Michael R Charlton | |||
| Colin L Colby | |||
| John J Poterucha | |||
| Joseph J Larson | |||
| John B Gross | |||
| Badr Al-Bawardy | |||
| Kathy Canterbury | |||
| P2860 | cites work | Telaprevir for retreatment of HCV infection | Q29619799 |
| Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options | Q29620126 | ||
| Sofosbuvir for previously untreated chronic hepatitis C infection | Q29620137 | ||
| Telaprevir for previously treated chronic HCV infection | Q34109057 | ||
| Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. | Q34320498 | ||
| Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection | Q34607097 | ||
| Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression | Q34787367 | ||
| Viral hepatitis C. | Q35617324 | ||
| Peginterferon and ribavirin for chronic hepatitis C. | Q36675912 | ||
| Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial | Q42981494 | ||
| Telaprevir and peginterferon with or without ribavirin for chronic HCV infection | Q42987218 | ||
| Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice | Q47669754 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic hepatitis C | Q55779873 |
| P304 | page(s) | 595-601 | |
| P577 | publication date | 2014-03-21 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C | |
| P478 | volume | 89 |
Search more.